[1]
Thomas Hedner and Jean Lycke, “CRISPR/Cas9 system and gene editing tools: On patent rights, recent disputes and its potential commercial applicability in biotechnology and medicine”, SIPLR, vol. 2, no. 1, pp. 12–23, Jun. 2019.